Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 22, 2026

Apr. 22, 2026

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

GlobeNewswire

Apr. 22, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

GlobeNewswire

Apr. 22, 2026

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée

GlobeNewswire

Apr. 22, 2026

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

GlobeNewswire

Apr. 22, 2026

George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage

GlobeNewswire

Apr. 22, 2026

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

GlobeNewswire

Apr. 22, 2026

Sight Sciences Announces the Release of its Sustainability Report

GlobeNewswire

Apr. 22, 2026

Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Apr. 22, 2026

Altimmune Announces Proposed Underwritten Public Offering of Securities

GlobeNewswire

Apr. 22, 2026

Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5

GlobeNewswire

Apr. 22, 2026

Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents

GlobeNewswire

Apr. 22, 2026

Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026

GlobeNewswire

Apr. 22, 2026

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

GlobeNewswire

Apr. 22, 2026

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

GlobeNewswire

Apr. 22, 2026

Abivax to Present Data on Obefazimod at Digestive Disease Week®

GlobeNewswire

Apr. 22, 2026

SkinHealth Systems Inc. Appoints Three New Independent Directors to Board

GlobeNewswire

Apr. 22, 2026

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Apr. 22, 2026

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

GlobeNewswire

Apr. 22, 2026

BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026

GlobeNewswire

Apr. 22, 2026

LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia

GlobeNewswire